Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case study observed that hijāmah bil shart (wet cupping) led to significant improvements in hair texture, reduced shedding, and overall scalp health in a 34-year-old male with androgenetic alopecia, with no adverse effects.

This pilot study found that using skin patting and iontophoresis to deliver a 6% dutasteride gel led to significant improvements in hair density and shaft diameter in men and postmenopausal women with treatment-resistant androgenetic alopecia, with no reported adverse events.

This study found that while platelet-rich plasma may be effective for alopecia areata, its superiority over intralesional steroid injections was not fully demonstrated, and side effects were more frequent.

This study evaluated eyebrow mesotherapy with a growth factor-based cocktail in 32 women with thin eyebrows, finding high satisfaction rates (90.6%) with significant improvements in density and appearance, low pain levels, and unanimous willingness to recommend the treatment.

This study evaluated the effects of autologous micrografts for androgenetic alopecia, reporting moderate improvements in hair loss reduction and hair density among most patients after treatment, with satisfactory results noted in patient satisfaction and treatment tolerability.

This study evaluated the effect of 308 nm excimer laser on alopecia areata, reporting that among 34 patches treated, 13% showed excellent response and 67% demonstrated moderate to good response, as assessed by dermoscopic indicators of disease remission and regrowth.

This study found that both intradermal botulinum toxin A and intradermal minoxidil were equally effective for treating androgenetic alopecia, showing improvement in hair count with advantages like minimal invasiveness and absence of major side effects; minoxidil was also noted to be more cost-effective.

In this study, a combination treatment of microinfusion (MMP®) and topical minoxidil showed a modest increase in hair density in a 28-year-old woman with chronic telogen effluvium, particularly in the parieto-vertex region, suggesting potential benefits but underscoring the need for larger trials to confirm efficacy.

In this study, seven patients with refractory alopecia areata treated with concentrated growth factor and microneedling-assisted betamethasone experienced significant hair regrowth, with one achieving over 50% regrowth and six showing complete recovery, without adverse effects.

This study evaluated microneedling's effect on hair loss, finding a minor reduction in SALT scores for androgenetic alopecia patients, but no significant change for fibrosing or alopecia areata groups. Further skin biopsy analyses are pending to explore other changes beyond SALT scores.

In this randomized controlled trial at Bolan Medical Complex Hospital, researchers observed that liquid nitrogen cryotherapy increased hair regrowth by 60% in alopecia areata patients, significantly outperforming alternative treatments, which achieved 40% regrowth.

This study found significant hair growth improvement with microneedling radiofrequency treatment in most patients with patterned hair loss, with minimal short-term adverse effects.

In this clinical trial, 16 women with frontal fibrosing alopecia experienced significant improvements in hair density, vellus hair count, and quality of life after monthly intralesional dutasteride treatments, though larger and longer-term studies are needed to confirm these findings.

This case study suggests that rose stem cell-derived exosomes, administered via noninvasive electroporation, may promote hair regeneration in androgenetic alopecia; larger studies are needed to confirm these findings.

In this interventional clinical study, 15 patients with scalp alopecia areata were treated with excimer laser weekly for 3 months, resulting in 26.7% achieving complete hair regrowth, while 46.7% showed no hair regrowth, indicating varied effectiveness of the treatment.

This study found that the novel dermal cooling system was an effective and safe treatment for reducing pigmentation in benign pigmented lesions in Asian patients, with minimal side effects.

In this study, a 40-year-old man with hair loss showed complete hair regrowth and no relapse 24 weeks after receiving umbilical cord mesenchymal stem cell and secretome injections, highlighting their potential for alopecia treatment, although further research involving larger populations is needed.

In this single-case study, researchers found that a combination of behavior and hypnotherapy led to positive psychological changes in a patient with Alopecia areata but did not result in hair regrowth, suggesting psychosomatic approaches may not address the hair loss mechanism.

This abstract introduces "Dermis," an open-access, peer-reviewed journal focused on dermatology, which publishes significant new research in the field of dermatology. Specific research results are not included here.

This study found that ring block anesthesia was the most acceptable method for reducing pain during platelet-rich plasma injections for hair loss.

In this study, researchers found that an injectable solution of low-molecular-weight hyaluronic acid and amino acids significantly improved skin rejuvenation and elasticity in the labia majora of post-menopausal women over 12 weeks, with a reported 25% or greater aesthetic improvement and high patient satisfaction.

In this study, an 18-year-old boy with alopecia areata successfully experienced normal and healthy hair regrowth after 4 months using microneedling with cupping, alongside internal herbal medication and topical oil application, as a cost-effective and less invasive alternative to high-cost hair treatments and transplantation.

This study suggests that fecal microbiota transplantation was effective in reducing symptoms of feline hyperesthesia syndrome, with most cats showing clinical remission or improvement and no observed side effects.

This study found that combining microneedling with a topical glycosaminoglycan lotion improved hair density and follicular thickness in patients with androgenetic alopecia, with no adverse effects except mild pain, suggesting potential synergistic benefits as a treatment.

In this case report, a 37-year-old woman with lupus panniculitis experienced successful restoration of volume in her right cheek using injectable hyaluronic acid filler after suffering from lipoatrophy.

This study found that a structured exercise program combining aerobic and resistance exercises significantly improved physical and emotional well-being in young women with PCOS.

This study demonstrated that polynucleotide gel injections effectively reduced hair shedding and increased hair thickness in both men and women with androgenetic alopecia, while maintaining a high safety profile and patient satisfaction.

This study found that intralesional vitamin D3 injections significantly improved hair regrowth in adults with patchy alopecia areata, as measured by a 5-point semiquantitative regrowth score and dermoscopic assessment, suggesting it may be an effective and affordable treatment.

This descriptive longitudinal study conducted in a Kolkata hospital found that intense pulsed light treatment significantly improved hirsutism in patients, as evaluated by trichoscopy and visual analog scores, demonstrating its effectiveness and safety for hair removal, independent of medical treatment.

This retrospective study found that intralesional betamethasone injections led to significant repigmentation in scalp vitiligo patients without leukotrichia, suggesting it as an effective treatment option.